| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |